CSF beta-amyloid levels are altered in narcolepsy: A link with the inflammatory hypothesis?

Journal of Sleep Research

Volumn 23, Issue 4, 2014, Pages 420-424

  Liguori, Claudio ^a   Placidi, Fabio ^a   Albanese, Maria ^a   Nuccetelli, Marzia ^a   Izzi, Francesca ^a   Marciani, Maria Grazia ^a,b   Mercuri, Nicola Biagio ^a,b   Bernardini, Sergio ^a   Romigi, Andrea ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

CSF; Narcolepsy; Orexin

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; OREXIN A; TAU PROTEIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NARCOLEPSY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY;

BETA-AMYLOID1-42; CSF; NARCOLEPSY; OREXIN;

ADOLESCENT; ADULT; AMYLOID BETA-PEPTIDES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NARCOLEPSY; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS; YOUNG ADULT;

EID: 84905024037     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/jsr.12130     Document Type: Article

References (20)

1. American Academy of Sleep Medicine ICSD-2 International Classification of Sleep Disorders, 2nd edn. Diagnostic and Coding Manual. American Academy of Sleep Medicine, Westchester, IL, 2005.
2. Burgess, C. R. and Scammell, T. E. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J. Neurosci., 2012, 32: 12305-12311.
3. Cvetkovic-Lopes, V., Bayer, L., Dorsaz, S., et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest., 2010, 120: 713-719.
4. De Strooper, B., Vassar, R. and Golde, T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol., 2010, 6: 99-107.
5. Fontana, A., Gast, H., Reith, W., Recher, M., Birchler, T. and Bassetti, C. L. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain, 2010, 133: 1300-1311.
6. Fredrikson, S., Carlander, B., Billiard, M. and Link, H. CSF immune variables in patients with narcolepsy. Acta Neurol. Scand., 1990, 81: 253-254.
7. Hickman, S. E., Allison, E. K. and El Khoury, J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci., 2008, 28: 8354-8360.
8. Honda, M., Arai, T., Fukazawa, M., et al. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy. Neurology, 2009, 73: 511-517.
9. Kallweit, U., Hidalgo, H., Engel, A., Baumann, C. R., Bassetti, C. L. and Dahmen, N. Post H1N1 vaccination narcolepsy-cataplexy with decreased CSF beta-amyloid. Sleep Med., 2012, 13: 323.
10. Kang, J. E., Lim, M. M., Bateman, R. J., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science, 2009, 326: 1005-1007.
11. Kornum, B. R., Faraco, J. and Mignot, E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr. Opin. Neurobiol., 2011, 21: 897-903.
12. Liguori, C., Sancesario, G., Albanese, M., Stefani, A., Marciani, M. G. and Pierantozzi, M. Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report. Mult. Scler., 2013, 19: 380-381.
13. Miyagawa, T., Miyadera, H., Tanaka, S., et al. Abnormally low serum acylcarnitine levels in narcolepsy patients. Sleep, 2011, 34: 349-353.
14. Miyagawa, T., Kawamura, H., Obuchi, M., et al. Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial. PLoS One, 2013, 8: e53707.
15. Nishino, S., Ripley, B., Overeem, S., Lammers, G. J. and Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000, 355: 39-40.
16. Poryazova, S., Hug, D. and Baumann, C. R. Narcolepsy and traumatic brain injury: cause or consequence? Sleep Med., 2011, 12: 811.
17. Sancesario, G. M., Esposito, Z., Nuccetelli, M., et al. Abeta1-42 detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation? Exp. Neurol., 2010, 223: 371-376.
18. Slats, D., Claassen, J. A., Lammers, G. J., Melis, R. J., Verbeek, M. M. and Overeem, S. Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls. Curr. Alzheimer Res., 2012, 9: 1119-1125.
19. Soscia, S. J., Kirby, J. E., Washicosky, K. J., et al. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One, 2010, 5: e9505.
20. Thannickal, T. C., Moore, R. Y., Nienhuis, R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000, 27: 469-474.